Dyrk1A-ASF-CaMKIIδ Signaling Is Involved in Valsartan Inhibition of Cardiac Hypertrophy in Renovascular Hypertensive Rats

Publisher： Karger

E-ISSN： 1421-9751|133|3|198-204

ISSN： 0008-6312

Source： Cardiology, Vol.133, Iss.3, 2016-0, pp. : 198-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dyrk1A-ASF-CaMKIIδ Signaling: New Mechanistic Insight Involved in Valsartan Inhibition of Cardiac Hypertrophy?

By  

Cardiology, Vol. 133, Iss. 4, 2015-12 ,pp. : 211-212

Karger

Access to resources Recommend Favorite

Inhibition of cardiac hypertrophy by probiotic-fermented purple sweet potato yogurt in spontaneously hypertensive rat hearts

By                

International Journal of Molecular Medicine, Vol. 30, Iss. 6, 2012-01 ,pp. : 1365-1375

Spandidos Publications

Access to resources Recommend Favorite

Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress

By  

THE JOURNAL OF PATHOLOGY, Vol. 235, Iss. 4, 2015-03 ,pp. : 606-618

John Wiley & Sons Inc

Access to resources Recommend Favorite

Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo

By                

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 499-506

Spandidos Publications

Access to resources Recommend Favorite

Erratum‐ovarian cancer cells, not normal cells, are damaged by mirk/dyrk1b kinase inhibition

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : E13-E13

John Wiley & Sons Inc

Access to resources Recommend Favorite